189 related articles for article (PubMed ID: 38783184)
21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
22. Examining the effect of Medicaid expansion on early detection of head and neck cancer of the oral cavity and pharynx by HPV-type and generosity of dental benefits.
Semprini J
Cancer Rep (Hoboken); 2023 Aug; 6(8):e1840. PubMed ID: 37248803
[TBL] [Abstract][Full Text] [Related]
23. Artificial intelligence for HPV status prediction based on disease-specific images in head and neck cancer: A systematic review and meta-analysis.
Song C; Chen X; Tang C; Xue P; Jiang Y; Qiao Y
J Med Virol; 2023 Sep; 95(9):e29080. PubMed ID: 37691329
[TBL] [Abstract][Full Text] [Related]
24. HPV DNA genotyping, HPV E6*I mRNA detection, and p16
Simoens C; Gorbaslieva I; Gheit T; Holzinger D; Lucas E; Ridder R; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
Cancer Epidemiol; 2021 Jun; 72():101925. PubMed ID: 33839457
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of HPV-Positive Tumors in Europe and in the World.
Castellsagué X; Mena M; Alemany L
Recent Results Cancer Res; 2017; 206():27-35. PubMed ID: 27699527
[TBL] [Abstract][Full Text] [Related]
26. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies.
Menezes FDS; Fernandes GA; Antunes JLF; Villa LL; Toporcov TN
Oral Oncol; 2021 Apr; 115():105177. PubMed ID: 33561611
[TBL] [Abstract][Full Text] [Related]
27. Head and neck cancer risk factors in India: protocol for systematic review and meta-analysis.
Poddar A; Aranha RR; K Muthukaliannan G; Nachimuthu R; Jayaraj R
BMJ Open; 2018 Aug; 8(8):e020014. PubMed ID: 30127047
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis.
Abogunrin S; Di Tanna GL; Keeping S; Carroll S; Iheanacho I
BMC Cancer; 2014 Dec; 14():968. PubMed ID: 25515630
[TBL] [Abstract][Full Text] [Related]
29. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
de Villiers EM; Gunst K; Stein H; Scherübl H
Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of human papillomavirus type-18 in head and neck cancer among the Chinese population: A PRISMA-compliant meta-analysis.
Yang F; Yin Y; Li P; Zhang X; Chen D; Liu Y; Wang J; Guo L
Medicine (Baltimore); 2019 Feb; 98(8):e14551. PubMed ID: 30813166
[TBL] [Abstract][Full Text] [Related]
31. [Human papilloma viruses: other risk factor of head and neck carcinoma].
Woto-Gaye G; M'Farrej MK; Doh K; Thiam I; Touré S; Diop R; Dial C
Bull Soc Pathol Exot; 2016 Aug; 109(3):160-4. PubMed ID: 27325173
[TBL] [Abstract][Full Text] [Related]
32. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
33. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of head and neck cancer.
Rettig EM; D'Souza G
Surg Oncol Clin N Am; 2015 Jul; 24(3):379-96. PubMed ID: 25979389
[TBL] [Abstract][Full Text] [Related]
35. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire.
Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940
[TBL] [Abstract][Full Text] [Related]
36. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
37. Do cutaneous human papillomavirus genotypes affect head and neck cancer? Evidence and bias-correction from a case-control study.
Al-Soneidar WA; Harper S; Madathil SA; Schlecht NF; Nicolau B
Cancer Epidemiol; 2022 Aug; 79():102205. PubMed ID: 35780522
[TBL] [Abstract][Full Text] [Related]
38. Infection of human papillomaviruses in cancers of different human organ sites.
Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
[TBL] [Abstract][Full Text] [Related]
39. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
Hwang TZ; Hsiao JR; Tsai CR; Chang JS
Int J Cancer; 2015 Jul; 137(2):395-408. PubMed ID: 25395239
[TBL] [Abstract][Full Text] [Related]
40. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.
Smith EM; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
Cancer Causes Control; 2010 Sep; 21(9):1369-78. PubMed ID: 20401530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]